Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy

Conditions: Intrahepatic Cholangiocarcinoma Interventions: Radiation: radioembolization with Y-90; Drug: Durvalumab; Drug: Cisplatin; Drug: Gemcitabine Sponsors: Francesco De Cobelli; Cardarelli Hospital; A.O. Ospedale Papa Giovanni XXIII; AOU Pisana, Pisa, Italy Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials